Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00225498 · ClinicalTrials.gov registry record · NA

Neurocognitive Effects of Ziprasidone: Relationship to Working Memory and Dopamine Blockade

A NA study of Schizophrenia, sponsored by Northwell Health.

Completed
Registry status
NA
Development phase
35
Enrollment target
1
Study location

NCT00225498 is a NA study of Schizophrenia that has completed, run by Northwell Health. The registered enrollment target is 35 participants, below the 219-participant average among 315 other Schizophrenia trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00225498, a NA study of Schizophrenia, has completed, sponsored by Northwell Health.

COMPLETED
Registry status
NA
Development phase
35 participants
Enrollment target
1
Study location

Study Summary

Ziprasidone is a newer drug intended for the treatment of the symptoms of schizophrenia. This new drug may have an added benefit of being able to help with some of the difficulties in problem solving and memory that many patients with schizophrenia experience. The present study wants to look at ziprasidone and two other drugs frequently used to treat the symptoms of schizophrenia (risperidone and olanzapine) to see if problem solving and memory get better with ziprasidone treatment. Moreover, we will look at symptoms and how they change with treatment.

Conditions Studied

Schizophrenia

Interventions

  • DRUG ziprasidone vs risperidone or olanzapine

Study Locations (1)

New York

  • The Zucker Hillside Hospital - Glen Oaks

Trial Details

FieldValue
Enrollment Target 35 participants
Start Date 2002-06
Est. Completion 2008-10
Phase NA

Sponsor

Northwell Health

370 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00225498

The ClinicalTrials.gov registry entry for NCT00225498 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 219-participant average among 315 other Schizophrenia trials with a reported enrollment target (84% lower). The listed sponsor is Northwell Health, which has 370 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Schizophrenia appearing as the primary indexed condition, and to 1 intervention - of which ziprasidone vs risperidone or olanzapine is the first listed.

NCT00225498 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT00225498 about?

NCT00225498 is a clinical study titled "Neurocognitive Effects of Ziprasidone: Relationship to Working Memory and Dopamine Blockade". Ziprasidone is a newer drug intended for the treatment of the symptoms of schizophrenia. This new drug may have an added benefit of being able to help with some of the difficulties in problem solving and memory that many patients with schizophrenia experience. The present study wants to look at zipr...

What is the current status of trial NCT00225498?

This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2002-06. Estimated completion is 2008-10.

What conditions does trial NCT00225498 study?

This clinical trial studies the following conditions: Schizophrenia.

What interventions are being tested in trial NCT00225498?

The interventions under investigation include: ziprasidone vs risperidone or olanzapine (DRUG).

Who is sponsoring clinical trial NCT00225498?

This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00225498 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Schizophrenia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Schizophrenia

All registered trials for this condition

New York

All trials with a study site in New York

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.